NYSE:CLColgate-Palmolive Stock Price, Forecast & News

$70.75

+0.49 (+0.70 %)

(As of 05/25/2020 04:00 PM ET)

Add

Compare

Today's Range

$70.02

Now: $70.75▼

$70.93

50-Day Range

$67.06

MA: $70.15▼

$73.42

52-Week Range

$58.49

Now: $70.75▼

$77.41

Volume3.43 million shs

Average Volume5.23 million shs

Market Capitalization$60.60 billion

P/E Ratio24.15

Dividend Yield2.49%

Beta0.6

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners. The company also provides home care products comprising dishwashing detergents, household cleaners, and fabric conditioners; pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. Its principal global and regional trademarks include Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. The company markets and sells its oral, personal, and home care products to various retailers, wholesalers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
Colgate-Palmolive has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 10 buy ratings, 4 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $76.00, Colgate-Palmolive has a potential upside of 7.4% from its current price of $70.75.
Amount of Analyst Coverage
Colgate-Palmolive has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.8 Community Rank

Outperform Votes
Colgate-Palmolive has received 473 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Colgate-Palmolive has received 851 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Colgate-Palmolive has received 64.27% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote “Outperform” if you believe CL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.

5.0 Dividend Strength

Dividend Leadership
Colgate-Palmolive is a leading dividend payer. It pays a dividend yield of 2.49%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Colgate-Palmolive has been increasing its dividend for 56 years.
Dividend Coverage
The dividend payout ratio of Colgate-Palmolive is 62.19 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Colgate-Palmolive will have a dividend payout ratio of 58.09 % next year. This indicates that Colgate-Palmolive will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Colgate-Palmolive insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,861,923.00 in company stock.
Percentage Held by Insiders
Only 0.78% of the stock of Colgate-Palmolive is held by insiders.
Percentage Held by Institutions
76.12% of the stock of Colgate-Palmolive is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Colgate-Palmolive are expected to grow by 5.57% in the coming year, from $2.87 to $3.03 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Colgate-Palmolive is 24.15, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.80.
Price to Earnings Ratio vs. Sector
The P/E ratio of Colgate-Palmolive is 24.15, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 35.16.
Price to Earnings Growth Ratio
Colgate-Palmolive has a PEG Ratio of 4.65. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Colgate-Palmolive has a P/B Ratio of 108.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Toilet preparations

Sub-IndustryHousehold Products

SectorConsumer Staples

Current SymbolNYSE:CL

Previous Symbol

CUSIP19416210

CIK21665

Webwww.colgatepalmolive.com

Phone212-310-2000

Debt

Debt-to-Equity Ratio21.51

Current Ratio0.96

Quick Ratio0.66

Price-To-Earnings

Trailing P/E Ratio24.15

Forward P/E Ratio24.65

P/E Growth4.65

Sales & Book Value

Annual Sales$15.69 billion

Price / Sales3.86

Cash Flow$3.45 per share

Price / Cash Flow20.49

Book Value$0.65 per share

Price / Book108.85

Profitability

EPS (Most Recent Fiscal Year)$2.83

Net Income$2.37 billion

Net Margins15.86%

Return on Equity942.99%

Return on Assets17.20%

Miscellaneous

Employees34,300

Outstanding Shares856,528,000

Market Cap$60.60 billion

Next Earnings Date7/24/2020 (Estimated)

OptionableOptionable

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

How has Colgate-Palmolive's stock been impacted by COVID-19 (Coronavirus)?

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CL shares have increased by 2.7% and is now trading at $70.75. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Colgate-Palmolive?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Colgate-Palmolive.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Colgate-Palmolive.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) posted its earnings results on Friday, May, 1st. The company reported $0.75 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.02. The business had revenue of $4.10 billion for the quarter, compared to analysts' expectations of $4.07 billion. Colgate-Palmolive had a net margin of 15.86% and a return on equity of 942.99%. The business's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.67 EPS. View Colgate-Palmolive's earnings history.

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Wednesday, March 11th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.44 per share on Friday, May 15th. This represents a $1.76 annualized dividend and a dividend yield of 2.49%. The ex-dividend date is Friday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.43. View Colgate-Palmolive's dividend history.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback program on Monday, June 18th 2018, which authorizes the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 9% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's leadership believes its stock is undervalued.

What price target have analysts set for CL?

16 brokerages have issued twelve-month target prices for Colgate-Palmolive's stock. Their forecasts range from $58.00 to $91.00. On average, they expect Colgate-Palmolive's stock price to reach $76.00 in the next year. This suggests a possible upside of 7.4% from the stock's current price. View analysts' price targets for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:

1. According to Zacks Investment Research, "Shares of Colgate have declined and underperformed the industry in the past six months, driven by its strained margin trend. In third-quarter 2019, escalated expenses of raw and packaging materials, including foreign-currency transaction costs, hurt gross margin. This coupled with higher SG&A expenses, as a rate of sales, hurt operating profits. Consequently, earnings fell year over year and are likely to decline in mid-single digits in 2019. Also, adverse currency impacts cannot be ignored. Nevertheless, Colgate expects strong top-line gains from accelerated investments in brands, pricing and innovation along with expansion in new markets and e-commerce capabilities. Moreover, it expects to sustain organic sales growth trend in 2019, backed by higher volume and pricing. Management now estimates organic sales growth of 3-4%." (11/4/2019)
2. Wells Fargo & Co analysts commented, "We are raising our price target by $3 to $68 to reflect CL’s fundamental progress to date, but maintain our Market Perform rating largely on valuation." (6/17/2019)

Has Colgate-Palmolive been receiving favorable news coverage?

Headlines about CL stock have trended very positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colgate-Palmolive earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutColgate-Palmolive.

Are investors shorting Colgate-Palmolive?

Colgate-Palmolive saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 10,750,000 shares, an increase of 9.0% from the April 30th total of 9,860,000 shares. Based on an average trading volume of 5,590,000 shares, the short-interest ratio is currently 1.9 days. Currently, 1.3% of the company's shares are sold short. View Colgate-Palmolive's Current Options Chain.

Who are some of Colgate-Palmolive's key competitors?

Some companies that are related to Colgate-Palmolive include Procter & Gamble (PG), Kimberly Clark (KMB), Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS). View all competitors.

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Coca-Cola (KO), Mcdonald's (MCD) and Intel (INTC).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the following people:

Mr. Ian M. Cook, Exec. Chairman (Age 66)
Mr. Noel R. Wallace, Pres, CEO & Director (Age 55)
Mr. Henning I. Jakobsen, Chief Financial Officer (Age 59)
Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 59)
Dr. Patricia D. Verduin Ph.D., Chief Technology Officer (Age 60)

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.88%), State Street Corp (5.00%), Massachusetts Financial Services Co. MA (4.10%), Wellington Management Group LLP (3.11%), Bank of New York Mellon Corp (2.17%) and Geode Capital Management LLC (1.66%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove. View institutional ownership trends for Colgate-Palmolive.

Which institutional investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, APG Asset Management N.V., APG Asset Management N.V., APG Asset Management N.V., BlackRock Inc., AQR Capital Management LLC, Canada Pension Plan Investment Board, and Loomis Sayles & Co. L P. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran. View insider buying and selling activity for Colgate-Palmolive.

Which institutional investors are buying Colgate-Palmolive stock?

CL stock was acquired by a variety of institutional investors in the last quarter, including Capital World Investors, Massachusetts Financial Services Co. MA, Nuveen Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, Mackenzie Financial Corp, The Manufacturers Life Insurance Company , Invesco Ltd., and Wellington Management Group LLP. View insider buying and selling activity for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $70.75.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $60.60 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

This page was last updated on 5/25/2020 by MarketBeat.com Staff